Compared with the KCNJ5 mutation carriers (12.5% vs. 79.3%, p < 0.001) and WT group (12.5% vs. 57.3%, p = 0.018), the CTNNB1 mutation carriers had a much lower chance of recovery from hypertension even after one-year follow-up. Here, KCNJ5 is linked to hypertensive disorder.